TRNS 📈 Transcat - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8935291075

TRNS: Calibration, Laboratory, Instruments, Services, Test, Measurement

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York. Web URL: https://www.transcat.com

Additional Sources for TRNS Stock

TRNS Stock Overview

Market Cap in USD 1,015m
Sector Industrials
Industry Industrial Distribution
GiC Sub-Industry Trading Companies & Distributors
IPO / Inception 1990-03-27

TRNS Stock Ratings

Growth 5y 82.1%
Fundamental 35.7%
Dividend -
Rel. Strength Industry -86.5
Analysts 4.4/5
Fair Price Momentum 107.11 USD
Fair Price DCF 47.13 USD

TRNS Dividends

No Dividends Paid

TRNS Growth Ratios

Growth Correlation 3m -61.2%
Growth Correlation 12m 26.5%
Growth Correlation 5y 93.8%
CAGR 5y 26.63%
CAGR/Mean DD 5y 2.00
Sharpe Ratio 12m 0.07
Alpha -20.98
Beta 0.68
Volatility 48.34%
Current Volume 96.5k
Average Volume 20d 57.5k
What is the price of TRNS stocks?
As of December 22, 2024, the stock is trading at USD 105.75 with a total of 96,540 shares traded.
Over the past week, the price has changed by -3.99%, over one month by +2.41%, over three months by -19.57% and over the past year by +2.42%.
Is Transcat a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Transcat (NASDAQ:TRNS) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.70 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRNS as of December 2024 is 107.11. This means that TRNS is currently overvalued and has a potential downside of 1.29%.
Is TRNS a buy, sell or hold?
Transcat has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy TRNS.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for TRNS stock price target?
According to ValueRays Forecast Model, TRNS Transcat will be worth about 117.9 in December 2025. The stock is currently trading at 105.75. This means that the stock has a potential upside of +11.5%.
Issuer Forecast Upside
Wallstreet Target Price 121.2 14.6%
Analysts Target Price 106.2 0.4%
ValueRay Target Price 117.9 11.5%